PRN is a leading producer of food-based medicines, often referred to as nutritional supplements or nutriceuticals. Omega-3 (EPA/DHA) essential fatty acids and certain vitamins are critical for good health. PRN products are designed to address a range of specific health conditions caused by an omega-3 or vitamin deficiency.
We stay current with the evidence and reformulate our products in response to the ever-evolving body of evidence. The company’s product-related assertions are made only when substantiated in well-documented peer-reviewed science and supported by the PRN Medical Director and International Scientific Advisory Panel.
Our medical team of physicians lectures at International, National, State and Local continuing education venues to provide the most current omega-3 research available. As all of our products are based on peer-reviewed clinical evidence, we enthusiastically provide accredited continuing education courses to ensure that our doctors are current on the latest omega-3 science.
Our Management Team
Kenneth A. Krieg | Chief Executive Officer
Ken has over 30 years of experience as a founder and CEO of numerous healthcare companies operating in healthcare services, hospital ambulatory and physician practice management. Ken served as Chairman of the Board, President/CEO of Omnia, Inc. During his tenure, Omnia successfully started and managed two of the country’s largest single specialty physician organizations under the L.L.C. format. Prior to that, Ken served as Chairman of the Board, President/CEO of Vanguard Healthcare Group. Under his direction, Vanguard grew to be one of the largest single specialty PPM’s in the country; with over 55 OB/GYN’s and Nurse Midwives accounting for nearly 25% of all births in Philadelphia County. Ken has written and lectured extensively on numerous organizational, operational and financial subjects in the healthcare service industry.
Michael B. Gross, M.D., FACOG | Chief Medical Officer & Executive Vice President
Mike is a nationally recognized expert in the emerging field of wellness and prevention. A graduate of Temple University School of Medicine, Mike went on to become a board-certified Obstetrician and Gynecologist. He distinguished himself in this field and served in the following leadership positions: Associate Professor at the Philadelphia College of Osteopathic Medicine, Medical Director of Vanguard OB/GYN Associates, National Medical Director for MedPartners Women’s Health, and Chairman of the Department of Obstetrics and Gynecology at Philadelphia’s Graduate Hospital, Parkview Division. He is a lifetime Fellow of the American College of Obstetricians and Gynecologists.
After many years in clinical practice and 15 years in physician practice management, Mike moved in a different direction to follow his life-long passion: wellness and prevention with particular emphasis on improving the healthcare experience. Collaborating with a multidisciplinary team, and serving as Chief Visionary/Program Director/and finally Director of New Business Development, he played a key role in the creation of the Health and Wellness Center by Doylestown Hospital, located in Bucks County, Pennsylvania. Opened in May 2001, this 130,000 square foot, state of the art outpatient wellness facility was designed to provide a superior experience for today’s demanding healthcare consumer. Mike served eight years as part of the visionary group which crafted this integrated, holistic healthcare model. As Director of New Business Development, he brought to this wellness facility the highest quality medical care and screening centers, a medically-based fitness center, spa services, café, and wellness boutique. Presently this building stands as a “best of breed” prototype for other similar facilities across the country as recognized by the Medical Advisory Board.
In pursuing his study of the best modalities in prevention for this health and wellness project, Mike learned about the benefits of polyunsaturated fatty acids (PUFAS) or Omega-3s. Medical research from numerous reputable institutions and journals clearly documents the numerous advantages of EPA and DHA, the essential fatty acids which are the essence of fish oil. His strong desire to help people avoid disease and reduce the effects of existing conditions led him to the development of his present company, PRN (Physician Recommended Nutriceuticals), whose mission is to provide the best Omega-3s and other evidence-based nutriceuticals in the marketplace today.
Michael Chaiken, OD | President – PRN Canada
Michael obtained his academic degrees from the State University of New York at Stony Brook and the School of Optometry, University of Montreal. A practicing optometrist and businessman for 33 years, he examined over 75,000 patients while being a board member of Quebec’s regulatory authority for 22 of those years and president for 8 of them. Michael had the honor of presenting legislative changes to the Quebec government in 1992 and 2000 that were adopted and allowed optometrists to diagnose and treat anterior segment eye disease. One of the original founders of the Canadian Optometric Regulatory Authorities (CORA), he worked towards the development of national optometric standards, interprovincial labor mobility agreements, coauthored many Quebec optometric regulations and is recognized as one of Canada’s leading authorities on optometric regulatory issues. He also worked closely with other professions in Quebec as administrator of the government mandated Interprofessional Council of Quebec. In recognition of his achievements Michael won the Quebec Association of Optometrists special Distinction Award “Optometrist of the Year” in 2001.
Drew M. Pinkin | Vice President & CFO
Overseeing PRN’s Finance and Accounting functions, including product procurement & distribution, Drew brings over 10 years of financial management and operational experience to the PRN organization, with 5 of those years in a nutriceutical environment. In his leadership role at PRN, Drew oversees all financial aspects of the business including corporate strategy and development, capital raising, acquisitions, investor relations, treasury and risk management activities, controller functions, corporate governance, compliance and taxes. Tactical activities include managing cash flow, forecasting and budgeting, financial reporting and business analysis, and contract negotiation. Prior to his current role, Drew held various positions including Director of Finance, Director of Operations for OmegaArthro (a subsidiary of LifeGuard Health) and Director of Practice Development & Support for Physician Recommended Nutriceuticals.
Prior to joining PRN, Drew held various operational positions at CCG Marketing Solutions in West Caldwell, NJ. CCG is a full-service marketing services provider offering specialized marketing services.
Drew holds an MBA degree from The University of Virginia Darden School of Business and a BA degree from Boston College.
Stefan Schoen | Vice President – Business Development
Stefan Schoen is the Vice President of Business Development. His responsibilities include various aspects of corporate strategic planning, research & product development, global commercial partnerships, and mergers & acquisitions. Stefan was appointed to his current position in November 2009. Prior to his current role, Stefan served as National Sales Director since PRN’s inception in 2006. Prior to joining PRN, Stefan worked for Sanofi-Aventis in the pharmaceutical division. Stefan has a BS in Business Administration from University of Mary